Ani Pharmaceuticals Inc (ANIP) — SC 13G Filings
All SC 13G filings from Ani Pharmaceuticals Inc. Browse 2 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (2)
-
Vanguard Discloses 9.1% Stake in ANI Pharmaceuticals
— Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an SC 13G on February 13, 2024, disclosing that as of December 29, 2023, they beneficially own 1,701,450 shar -
Rubric Capital Exits ANI Pharma Stake as of Dec 31, 2023
— Feb 12, 2024 Risk: medium
Rubric Capital Management LP, a New York-based investment firm, filed an SC 13G on February 12, 2024, disclosing that as of December 31, 2023, they beneficially
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX